Cargando…

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder in which the major pathologic substrate is a loss of dopaminergic neurons from the substantia nigra. Our main objective was to determine the correspondence between changes in the substantia nigra, evident in neuromelanin and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaias, Ioannis U., Trujillo, Paula, Summers, Paul, Marotta, Giorgio, Mainardi, Luca, Pezzoli, Gianni, Zecca, Luigi, Costa, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992725/ https://www.ncbi.nlm.nih.gov/pubmed/27597825 http://dx.doi.org/10.3389/fnagi.2016.00196

Ejemplares similares

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2018)

The Influence of Dopaminergic Striatal Innervation on Upper Limb Locomotor Synergies
por: Isaias, Ioannis U., et al.
Publicado: (2012)

A role for locus coeruleus in Parkinson tremor
por: Isaias, Ioannis U., et al.
Publicado: (2012)

Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson’s Disease
por: Canessa, Andrea, et al.
Publicado: (2016)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

The protective and toxic role of neuromelanins in brain aging and Parkinson’s disease
por: Zecca, Luigi, et al.
Publicado: (2015)

Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease
por: Isaias, Ioannis U, et al.
Publicado: (2011)

Brain metabolic alterations herald falls in patients with Parkinson’s disease
por: Isaias, Ioannis U., et al.
Publicado: (2020)

Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
por: Zucca, Fabio A., et al.
Publicado: (2022)

Tracemetals, neuromelanin and neurodegeneration: An interesting area for research
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2007)

Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
por: Capucciati, Andrea, et al.
Publicado: (2021)

Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease
por: Zucca, Fabio A., et al.
Publicado: (2018)

Gait Initiation Impairment in Patients with Parkinson’s Disease and Freezing of Gait
por: Palmisano, Chiara, et al.
Publicado: (2022)

Gait Initiation in Parkinson’s Disease: Impact of Dopamine Depletion and Initial Stance Condition
por: Palmisano, Chiara, et al.
Publicado: (2020)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
por: Nagatsu, Toshiharu, et al.
Publicado: (2022)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
por: Dukart, Juergen, et al.
Publicado: (2017)

Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
por: Tiklová, Katarína, et al.
Publicado: (2021)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
por: Wang, Shangpei, et al.
Publicado: (2023)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus
por: Wakamatsu, Kazumasa, et al.
Publicado: (2015)

Gait initiation in progressive supranuclear palsy: brain metabolic correlates
por: Palmisano, Chiara, et al.
Publicado: (2020)

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
por: Ivanidze, Jana, et al.
Publicado: (2020)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
por: Liu, Qiang, et al.
Publicado: (2023)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2020)

Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure
por: Engelen, Mireille, et al.
Publicado: (2012)

A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2019)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Mechanical Energy Recovery during Walking in Patients with Parkinson Disease
por: Dipaola, Mariangela, et al.
Publicado: (2016)

Phospho-HDAC6 Gathers Into Protein Aggregates in Parkinson’s Disease and Atypical Parkinsonisms
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia
por: Watanabe, Yoshiyuki, et al.
Publicado: (2014)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Reduction of the Nitro Group to Amine by Hydroiodic Acid to Synthesize o-Aminophenol Derivatives as Putative Degradative Markers of Neuromelanin
por: Wakamatsu, Kazumasa, et al.
Publicado: (2014)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
por: Ortelli, Paola, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_05q08hp9u48fe5ruje2mukg7hl